Pāriet uz galveno navigāciju Pāriet uz meklēšanu Pāriet uz galveno saturu

Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): Evaluation in vitro and in vivo

  • Ants Kask
  • , Felikss Mutulis
  • , Ruta Muceniece
  • , Rein Pähkla
  • , Ilze Mutule
  • , Jarl E.S. Wikberg
  • , Lembit Rägo
  • , Helgi B. Schiöth*
  • *Šī darba korespondējošais autors
  • University of Tartu
  • Latvijas Organiskās sintēzes institūts
  • Uppsala University

Zinātniskās darbības rezultāts: Devums žurnālam › Zinātniskais raksts (žurnālā) › koleģiāli recenzēts

153 Atsauces (Scopus)

Kopsavilkums

Several novel cyclic MSH analogs were synthesized, and their binding properties were tested on cells transiently expressing the human melanocortin-1 (MC1), MC3, MC4, and MC5 receptors. We discovered a novel substance (HS024) that showed about 20-fold selectivity and very high affinity (K(i) = 0.29 nM) for the MC4 receptor. HS024 (cyclic [AcCys3,Nle4,Arg5,D-Nal7,Cys-NH211]α-MSH-(3-11)) has a 29-membered atom ring structure that includes an Arg in position 5. HS024 was found to antagonize an αMSH-induced cAMP response in cells expressing the human MC1, MC3, MC4, and MC5 receptor DNAs. HS024 also caused a dose-dependent increase in food intake, with a maximum response (4-fold increase) at a 1-nmol dose injected intracerebroventricularly in free feeding rats. We also tested SHU9119, a previously described nonselective MC receptor antagonist, and found HS024 and SHU9119 to have similar potencies for increasing food intake, although SHU9119 appeared to induce more serious side-effects. HS024 increased the food intake of free feeding rats to levels comparable to those in food-deprived rats, indicating that blockade of the MC4 receptor is a highly effective way to increase feeding. Moreover, we tested the effects of intracerebroventricular rejections of HS024 in elevated plus-maze and open- field experiments on rats. In these tests, HS024 did not appear to affect emotionality or locomotor activity, suggesting that the MC4 receptor does not mediate the anxiogenic-like and locomotor effects related to the melanocortic peptides.

OriģinālvalodaAngļu
Lapas (no-līdz)5006-5014
Lapu skaits9
ŽurnālsEndocrinology (United States)
Sējums139
Izdevuma numurs12
DOIs
Publikācijas statussPublicēts - 1998
Ārēji publicētsJā

ANO IAM

Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)

  1. 3. IAM — Laba Veselība un Labbūtība
    3. IAM — Laba Veselība un Labbūtība

Nospiedums

Uzziniet vairāk par pētniecības tēmām “Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): Evaluation in vitro and in vivo”. Kopā tie veido unikālu nospiedumu.

Citēt šo